Article citationsMore>>
D. R. Camidge, R. S. Herbst, M. S. Gordon, S. G. Eckhardt, R. Kurzrock, B. Durbin, J. Ing, T. M. Tohnya, J. Sager, A. Ashkenazi, et al., “A Phase I Safety and Pharmacokinetic Study of the Death Receptor 5 Agonistic Antibody PRO95780 in Patients with Advanced Malignancies,” Clinical Cancer Research, Vol. 16, No. 4, 2010, pp. 1256-1263.
http://dx.doi.org/10.1158/1078-0432.CCR-09-1267
has been cited by the following article: